Literature DB >> 5202

Effects of regional ischemia on metabolism of glucose and fatty acids. Relative rates of aerobic and anaerobic energy production during myocardial infarction and comparison with effects of anoxia.

L H Opie.   

Abstract

The rate of coronary flow reaching the oxygen-linited heart appears to be crucial in determining the myocardial tissue metabolic response. The tissue metabolic response to anoxia, well studied in hearts perfused with anoxic media, differs in many important ways from the response to ischemia. In regional ischemia (developing infarction) there is still a residual oxygen uptake which is reduced approximately to the same extent as the delivery of O2; there is also decreased delivery of substrates and decreased removal of CO2, H+, and lactate, with increased concentrations of these metabolites. Contents of hexose monophosphates rise rather than fall in anoxia. Measurements of glycolytic intermediates show an initial burst of accelerated glycolytic flux lasting less than 1 minute after coronary artery ligation; thereafter rates of flux decrease to control values or even less at 120 minutes. Relative inhibition of phosphofructokinase (PFK) activity may be explained by a slow rate of fall of ATP and a developing intracellular acidosis. In this model, glucose accounts for a greater part of the residual oxidative metabolism than does free fatty acid (FFA).

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 5202

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  61 in total

Review 1.  Myocardial fatty acid oxidation during ischemia and reperfusion.

Authors:  R Lerch; C Tamm; I Papageorgiou; R H Benzi
Journal:  Mol Cell Biochem       Date:  1992-10-21       Impact factor: 3.396

Review 2.  KATP Channels in the Cardiovascular System.

Authors:  Monique N Foster; William A Coetzee
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

Review 3.  Imaging techniques in nuclear cardiology for the assessment of myocardial viability.

Authors:  Riemer H J A Slart; Jeroen J Bax; Dirk J van Veldhuisen; Ernst E van der Wall; Rudi A J O Dierckx; Pieter L Jager
Journal:  Int J Cardiovasc Imaging       Date:  2005-12-13       Impact factor: 2.357

4.  Alcohol consumption improves insulin signaling in the myocardium.

Authors:  Nassrene Y Elmadhun; Antonio D Lassaletta; Thomas Burgess; Ashraf A Sabe; Frank W Sellke
Journal:  Surgery       Date:  2013-08       Impact factor: 3.982

Review 5.  Myocardial ischemia--metabolic pathways and implications of increased glycolysis.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

6.  AMP-activated protein kinase connects cellular energy metabolism to KATP channel function.

Authors:  Hidetada Yoshida; Li Bao; Eirini Kefaloyianni; Eylem Taskin; Uzoma Okorie; Miyoun Hong; Piyali Dhar-Chowdhury; Michiyo Kaneko; William A Coetzee
Journal:  J Mol Cell Cardiol       Date:  2011-08-24       Impact factor: 5.000

7.  Effects of ranolazine on left ventricular regional diastolic function in patients with ischemic heart disease.

Authors:  W Hayashida; C van Eyll; M F Rousseau; H Pouleur
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

8.  Metabolic fate of extracted glucose in normal human myocardium.

Authors:  J A Wisneski; E W Gertz; R A Neese; L D Gruenke; D L Morris; J C Craig
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

9.  Effects of iloprost, a PGI2 derivative, on ischemic myocardial energy and carbohydrate metabolism in dogs.

Authors:  K Ichihara; K Yamamoto; Y Abiko
Journal:  Mol Cell Biochem       Date:  1993-02-17       Impact factor: 3.396

10.  Prognosis of hypertrophic cardiomyopathy: assessment by 123I-BMIPP (beta-methyl-p-(123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography.

Authors:  T Nishimura; S Nagata; T Uehara; T Morozumi; Y Ishida; T Nakata; O Iimura; C Kurata; Y Wakabayashi; H Sugihara; K Otsuki; T Wada; Y Koga
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.